Federal charges allege illegal payments to nurses for patient referrals tied to high-payout wound-care billing
WASHINGTON, DC, August 26, 2026 — Federal prosecutors have charged Sarasota advanced practice registered nurse Leigh Tesar in a Medicare health care fraud case alleging paid patient referrals, high-priced wound allografts, falsified clinical records, and more than $118 million in claims generated over eighteen months.
The ten-count indictment, returned June 17 in the Middle District of Florida, also names registered nurses Walter Presha Junior and Koby Evans, whom prosecutors accuse of directing Medicare beneficiaries toward Tesar in exchange for compensation presented on paper as sales-related income.
According to the Justice Department’s official announcement of the charges, Medicare paid approximately $61 million on claims the government characterizes as fraudulent, while investigators seized approximately $11.8 million from accounts allegedly connected with proceeds generated through the operation.
The charging document does not establish guilt, however, and Tesar, Presha, and Evans remain presumed innocent unless prosecutors prove every required element beyond a reasonable doubt through admissible evidence or a defendant voluntarily enters a legally accepted guilty plea.
Kickback allegations form the prosecution’s spine
Although the Leigh Tesar Medicare fraud case includes detailed accusations about unnecessary products and services never performed, its kickback theory supplies the connective tissue linking alleged patient recruitment, product selection, clinical treatment, Medicare reimbursement, distributor payments, and money deposited into referral-related business accounts.
Federal law generally prohibits knowingly and willfully offering, paying, soliciting, or receiving remuneration to induce referrals for items or services reimbursable by a federal health care program, meaning both the alleged payer and the alleged recipient can face separate criminal exposure.
Prosecutors portray Tesar as the Medicare-enrolled clinician and Primecare operator who could order allografts, apply them to beneficiary wounds, and submit claims, while Presha and Evans allegedly supplied the patients whose treatment produced the reimbursable business that fed the arrangement.
The indictment identifies Tesar Primecare as a Sarasota clinic or group practice and describes an unnamed Pennsylvania business, called Company One in court papers, that marketed allografts and allegedly passed referral compensation through agreements that appeared to be conventional sales relationships.
Those sales agreements were shams, prosecutors allege, because the purported representatives were not principally rewarded for independent product marketing, education, or legitimate commercial development, but instead for locating Medicare beneficiaries with wounds and steering those beneficiaries toward Tesar’s high-value treatment pipeline.
How the alleged referral engine operated
Presha allegedly owned Universal Nursing and Wellness and registered the fictitious name W.P. Enterprises, while Evans allegedly owned Healing His Way, creating business identities and bank accounts that the government says received payments originating from the distributor involved in the allograft transactions.
According to prosecutors, Tesar recruited and worked with these purported representatives to identify Medicare beneficiaries, order expensive wound products from Company One, apply or purportedly apply those products, and cause Primecare to bill Medicare after each patient entered the alleged referral network.
The indictment cites a June 5, 2024, text in which Tesar allegedly discussed moving “room to room looking for wounds” before adding “that might be illegal, but oh well,” language prosecutors will likely use when arguing knowledge and intent.
On September 16, 2024, Tesar allegedly told Presha that his associated invoices totaled approximately $4.07 million, referenced a twenty-percent calculation, and sent a calculator image displaying approximately $813,925, making the alleged compensation formula unusually concrete within the charging narrative.
That exchange matters because a percentage tied to invoiced product value can allow referral compensation to rise automatically whenever the number of patients, treatment area, product price, or frequency of applications increases, according to the economic logic embedded in the government’s theory.
On January 6, 2025, prosecutors say Tesar introduced Evans to an owner of Company One by explaining that Evans had several patients who could begin quickly, an alleged introduction that joined patient sourcing, distributor access, and anticipated allograft use within a single communication.
Later that month, Tesar allegedly explained that a new product cost $2,000 per square centimeter rather than $1,591 and told Evans his twenty-percent share would therefore increase, after first clarifying that she was discussing product cost instead of reimbursement.
The following day, according to the indictment, Tesar sent Presha similar pricing information and said she intended to switch patients toward the more expensive product, an allegation that prosecutors may present as evidence that financial return influenced clinical product selection.
In April 2025, after discussing the amount and timing of anticipated payments with Evans, Tesar allegedly warned that she was “not supposed to discuss money” with the representatives, a message prosecutors may characterize as evidence of concealment rather than ordinary administrative caution.
The alleged paper trail continued in July 2025, when Tesar reportedly emailed a Company One owner with Primecare payments, allograft products, patient identifiers, and associated representatives, information that prosecutors say enabled the distributor to calculate and send the disputed compensation.
On August 15, 2025, the indictment says Company One deposited approximately $397,570 into the W.P. Enterprises account connected with Presha and approximately $10,998 into the Healing His Way account connected with Evans, transactions charged as both paid and received kickbacks.
Why the twenty-percent calculation could matter
Compensation does not become criminal merely because a medical company pays a salesperson, but prosecutors frequently examine whether money reflects legitimate work at fair market value or instead varies with referrals, federally reimbursed business, claim value, or treatment volume.
Here, the government will likely argue that the alleged twenty-percent formula transformed beneficiaries into revenue-producing inputs because larger invoices generated larger representative payments, while the provider, distributor, and recruiter each allegedly benefited when more costly allografts reached the Medicare billing system.
The defendants may challenge that interpretation by arguing that payments compensated lawful services, that communications lack the context prosecutors assign them, that pricing discussions were commercially ordinary, or that particular patient referrals and bank deposits were not knowingly exchanged as unlawful remuneration.
Any statutory exception or regulatory safe harbor would depend upon the arrangement’s complete facts, including written terms, fair-market-value compensation, services actually performed, independence from referral volume or value, and the participants’ understanding, rather than whatever occupational label appeared on an agreement.
Because criminal kickback charges require proof that conduct was knowing and willful, the parties’ messages, contracts, invoices, calendars, patient assignments, corporate records, and testimony may matter more than the mere movement of money between health care businesses.
Prosecutors can also connect circumstantial evidence across separate events, arguing that percentage calculations, patient introductions, product switching, secrecy warnings, representative mappings, and bank deposits collectively reveal a referral bargain even if no single document expressly records every term.
Defense lawyers, meanwhile, can test whether each message is authentic and complete, whether speakers used shorthand, whether witnesses interpreted conversations reliably, whether payments matched documented services, and whether the government has confused aggressive commerce with the specific criminal intent required by law.
High-value allografts amplified the alleged incentives
The wound products described by prosecutors are bioengineered skin substitutes, including allografts derived from placental tissue, which can support wound closure when medically appropriate but can also generate extraordinary reimbursement amounts because product costs may be calculated across each treated square centimeter.
That pricing structure is critical to the alleged scheme because even a modest percentage can produce substantial compensation when multiplied by expensive products, large wound measurements, repeated applications, numerous beneficiaries, and claims whose reimbursable values reach hundreds of thousands of dollars.
Medicare Part B reimburses qualified providers for covered, reasonable, and necessary care, while requiring accurate claim information, truthful clinical documentation, services furnished as represented, and compliance with program rules, including the federal prohibition against purchasing federally reimbursed referrals.
First Coast Service Options, the Medicare administrative contractor identified in the indictment, maintained coverage requirements addressing wound improvement, conservative treatment, infection control, underlying medical conditions, product switching, repeated applications, and each patient’s realistic potential for restoration.
Prosecutors allege Tesar applied allografts without attempting or confirming adequate conservative treatment, continued applications after wounds failed to respond, treated infected wounds, and used products on terminally ill patients whose wounds allegedly could not heal under their medical circumstances.
Those medical-necessity accusations remain distinct from the alleged kickbacks, yet they reinforce the government’s broader theory that financial incentives displaced individualized judgment, especially when prosecutors contend Tesar selected products solely to maximize profit and contemplated switching patients toward higher-cost material.
The indictment also accuses Tesar and others of falsifying records by documenting treatments that never occurred, inventing earlier wound documentation, misreporting patient conditions, and claiming Tesar personally provided conservative care that prosecutors say was never administered as represented.
In still other instances, authorities allege Medicare was billed for allografts or application services that beneficiaries never received, potentially allowing prosecutors to present straightforward non-performance evidence alongside more nuanced disputes requiring expert testimony about medical necessity, healing potential, and accepted wound-care practice.
Beneficiaries were allegedly encouraged to begin or continue costly treatment through misrepresented expenses, unlawfully waived copayments, free medical supplies, and valuable gifts including jewelry and a leather recliner, adding patient inducements to the referral and billing allegations already described.
Five claims anchor the health care fraud counts
Counts one through five charge Tesar with health care fraud and aiding or abetting specific executions, identifying five anonymized beneficiaries whose disputed claims collectively sought approximately $3.96 million and generated approximately $2.82 million in payments between October 2024 and August 2025.
The smallest identified execution allegedly involved approximately $288,350 billed and $199,769 paid, while the largest allegedly involved approximately $1.11 million billed and $854,311 paid, illustrating how individual allograft episodes could produce unusually large federal reimbursements under the government’s calculations.
Those five charged claims do not represent the prosecution’s entire alleged loss amount, because the narrative portion asserts that Tesar and others caused more than $118 million in submissions and obtained more than $61 million from Medicare across the broader eighteen-month period.
Count six accuses all three defendants of conspiring to defraud the United States and to offer, pay, solicit, and receive health care kickbacks, allegedly to enrich participants, conceal payments, and impair federal administration and oversight of Medicare.
Counts seven and eight accuse Tesar of offering and paying the two August 2025 kickbacks, while counts nine and ten accuse Presha and Evans, respectively, of soliciting and receiving those same deposits for referring beneficiaries needing federally reimbursable wound-care products and services.
This structure permits prosecutors to argue several related theories without treating them as interchangeable, because a jury could separately evaluate alleged false claims, the alleged referral conspiracy, payments attributed to Tesar, and receipts attributed to Presha or Evans.
It also means each defendant’s exposure depends upon evidence connected to that person’s conduct and state of mind, rather than guilt by professional association, shared industry, business proximity, or the substantial overall billing number featured prominently in public announcements.
Arrests, bond conditions, and presumed innocence
Local reporting based on federal court records says Tesar, Presha, and Evans were arrested and released June 18, with respective bonds of $1 million, $250,000, and $100,000 while the federal prosecution proceeds in Tampa.
Release on bond neither resolves the evidence nor signals how a court views ultimate guilt, because pretrial release decisions address appearance, safety, conditions, and statutory detention standards rather than deciding whether prosecutors can prove charged conduct at a future trial.
The government’s forceful language likewise remains advocacy embodied in a grand jury charging document, which is tested through disclosure, motions, evidentiary objections, cross-examination, expert analysis, defense proof, judicial instructions, and the constitutional presumption that follows every defendant into court.
No responsible account should describe the alleged kickbacks, medical-record falsification, unnecessary treatment, personal spending, or false billing as established fact unless later proceedings produce admissions, findings, or a verdict supporting those propositions through the applicable legal standard.
Seizures and forfeiture raise a second financial contest
The government says it seized approximately $11.8 million associated with Tesar, including funds taken from accounts at Bank of America, Fidelity Investments, and Cogent Bank between July and October 2025, before the grand jury returned the June 2026 indictment.
The forfeiture allegations seek approximately $61.63 million from Tesar, approximately $3.19 million from Presha, and approximately $263,223 from Evans, figures the government characterizes as proceeds obtained through the charged offenses rather than automatically forfeited property already awarded to the United States.
Prosecutors further allege fraud proceeds supported more than $215,000 in Tampa Bay Buccaneers tickets and a luxury suite at Raymond James Stadium, alongside more than $400,000 in fine art, expenditures likely intended to illustrate both motive and personal benefit.
Those purchases may attract public attention, but their evidentiary significance will depend upon tracing, admissibility, disputed ownership, legitimate income, and the connection prosecutors can establish between particular expenditures and criminal proceeds rather than merely expensive preferences or conspicuous consumption.
Forfeiture remains contingent and independently contestable, allowing defendants and qualifying third parties to dispute traceability, commingling, ownership, substitute-property treatment, and the government’s calculation of gross proceeds even if criminal liability is later established on one or more counts.
A Florida case within a national enforcement campaign
The Tesar prosecution arrived through the Justice Department’s 2026 National Health Care Fraud Takedown, which announced charges against 455 defendants, including ninety doctors and other licensed professionals, across fifty-six federal districts and forty-five states and territories involving more than $6.5 billion in alleged claims.
Federal authorities said the coordinated operation produced more than $182 million in seizures across cash, real estate, vehicles, jewelry, and other property, while advanced claims analytics helped investigators identify extreme billing, concentrated providers, suspicious product utilization, and potentially connected financial beneficiaries.
Wound allograft cases are particularly suited to data-driven scrutiny because investigators can compare provider totals, square-centimeter usage, product prices, application frequency, patient diagnoses, wound measurements, geographic concentration, referral sources, and payment destinations across millions of standardized Medicare claim records.
Once investigators identify an outlier, they can move from statistical patterns to patient charts, product invoices, photographs, electronic messages, bank transfers, corporate registrations, and witness interviews, creating a layered record that combines national analytics with evidence tied to individual treatments and transactions.
For compliance teams, the alleged warning signs include percentage compensation linked to product invoices, sudden shifts toward more expensive materials, representatives supplying patients rather than marketing products, copayment waivers, valuable beneficiary gifts, questionable documentation, and payments routed through distributor-associated business accounts.
The indictment also alleges that after a Medicare audit began, Tesar removed her name as Primecare’s owner from Florida corporate records while retaining ownership and managerial control, conduct prosecutors characterize as an attempt to avoid scrutiny over continuing claim submissions.
That accusation will require proof rather than inference, yet it demonstrates why ownership filings, provider enrollment data, management authority, banking control, and audit communications often become central when investigators examine whether organizational changes reflected legitimate restructuring or concealment.
Public allegations create consequences before trial
A nationally publicized Medicare indictment can immediately affect clinical relationships, insurer participation, licensing scrutiny, employee confidence, banking access, referral sources, search results, and personal reputation, even though the criminal process may take months or years to produce a final resolution.
Professionals confronting comparable publicity may require carefully coordinated crisis public relations management that preserves evidence, respects court restrictions, aligns public statements with defense strategy, corrects demonstrable errors, and avoids presenting unresolved allegations as either proven misconduct or fabricated persecution.
Longer-term reputation rebuilding strategies can emphasize accurate procedural updates, verified credentials, documented reforms, transparent accountability, and durable public-interest information, while never attempting to suppress legitimate reporting, mislead patients, manipulate court records, or conceal material facts.
Nothing in publicly reviewed materials indicates that Amicus International Consulting represents Tesar, Presha, Evans, Primecare, or any related organization, and these communications observations are included solely to explain the predictable reputational pressures accompanying heavily indexed federal health care allegations.
Fair coverage should therefore identify every contested assertion as an allegation, distinguish charges from proof, avoid assigning collective guilt, and update the public if later motions, pleas, dismissals, acquittals, convictions, sentencing decisions, or forfeiture judgments materially alter the available record.
What prosecutors and defense lawyers must address next
If the case reaches trial, prosecutors are likely to organize their presentation around messages, patient referrals, allograft invoices, Medicare claims, clinical charts, distributor records, bank deposits, corporate filings, witness testimony, and expert opinions explaining how legitimate wound-care and sales arrangements ordinarily function.
Defense counsel can respond by separating medical judgment from reimbursement disputes, testing whether alleged referrals were actually compensated, challenging the government’s loss methodology, disputing message interpretations, examining each patient individually, and requiring proof that every defendant acted knowingly and willfully.
The medical and kickback theories may reinforce one another, but neither automatically proves the other, because an unnecessary treatment is not necessarily referral bribery, while a prohibited referral payment can potentially taint reimbursed business even when a patient received a clinically useful product.
That distinction will be essential as jurors evaluate whether the government has established a deliberate referral-for-payment structure, whether the charged claims were knowingly false, whether disputed treatments met Medicare requirements, and whether each defendant possessed the criminal intent prosecutors allege.
For now, the DOJ’s case against APRN Leigh Tesar, Walter Presha Junior, and Koby Evans remains an unresolved federal prosecution whose alleged twenty-percent compensation model gives the kickback counts unusual specificity, but whose conclusions must ultimately emerge from evidence and due process.